PICCs are a reliable alternative to short-term central venous catheters, with a lower risk of complications. Early assessment of hospitalized patients is essential to assure that individuals who ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...